Stratasys Ltd. (NASDAQ: SSYS) right now introduced the launch of its J5™ Digital Anatomy™ 3D printer, the most recent innovation designed to deal with the rising demand for cost-effective, high-fidelity anatomical fashions. This Stratasys innovation is designed to allow hospitals, medical machine producers and analysis establishments to reinforce affected person outcomes, streamline operations and convey merchandise to market quicker.
This press launch options multimedia. View the complete launch right here: https://www.businesswire.com/information/residence/20240619265067/en/
The brand new J5™ Digital Anatomy™ 3D printer from Stratasys. (Picture: Enterprise Wire)
Stratasys will host an official reveal of the printer on June 25th at 2:30 p.m. (Pacific) at RAPID + TCT. Attendees are welcome to affix the celebration on the firm’s sales space then, or at any time through the occasion, to see first-hand how the printer, with its compact footprint and distinctive materials capabilities, delivers unmatched precision and realism in anatomical modeling.
Key Advantages for Prospects:
- Enhanced surgical planning: The J5 Digital Anatomy printer produces life-like, patient-specific anatomic fashions that permit for pre-operative surgical planning and should help in lowering working room time and related prices. Utilizing such fashions additionally assists in enhancing communication between the medical workers and between the workers and their sufferers.
- Expertise anatomy like by no means earlier than: Distinctive realism in cost-effective coaching sources, growing accessibility to inexpensive high-quality instructing instruments.
- Accelerated growth: The flexibility to create exact, repeatable anatomical fashions that allow fast iterations in medical machine growth, probably lowering the necessity for animal testing and shortening time to market.
“The J5 Digital Anatomy printer is designed to be user-friendly and facility-friendly, making superior anatomical modeling accessible to a broader vary of medical establishments,” mentioned Erez Ben Zvi, VP Medical, Stratasys.
Product Capabilities:
- Biomechanically correct supplies: Helps the manufacturing of fashions that mimic the conduct and response of actual human tissue, skeletal buildings and vasculature, offering real looking haptic suggestions for procedures resembling suturing, incision, and screw insertion, whereas bearing true-to-life radiopacity traits with supported imaging.
- Compact and accessible: The J5 Digital Anatomy printer is a simple to make use of, office-friendly printer with a small footprint and a decrease Complete Value of Possession (TCO), making it a perfect selection for establishments going through funds and house limitations.
Stratasys continues to cleared the path in superior 3D printing options that improve affected person care and advance medical analysis. For extra details about the J5 Digital Anatomy printer and Stratasys’ complete vary of medical options, go to www.stratasys.com.
About Stratasys:
Stratasys is main the worldwide shift to additive manufacturing with revolutionary 3D printing options for industries resembling aerospace, automotive, client merchandise and healthcare. Via sensible and related 3D printers, polymer supplies, a software program ecosystem, and components on demand, Stratasys options ship aggressive benefits at each stage within the product worth chain. The world’s main organizations flip to Stratasys to remodel product design, convey agility to manufacturing and provide chains, and enhance affected person care.
To be taught extra about Stratasys, go to www.stratasys.com, the Stratasys weblog, Twitter, LinkedIn, or Fb. Stratasys reserves the appropriate to make the most of any of the foregoing social media platforms, together with Stratasys’ web sites, to share materials, personal info pursuant to the SEC’s Regulation FD. To the extent obligatory and mandated by relevant regulation, Stratasys may even embody such info in its public disclosure filings.
Stratasys, J5 and Digital Anatomy are logos or registered logos of Stratasys Ltd. and/or its associates. All different logos are the property of their respective house owners.
Word Concerning Ahead-Trying Assertion
The statements on this press launch concerning Stratasys are “forward-looking statements” inside the which means of the Personal Securities Litigation Reform Act of 1995, Part 27A of the Securities Act of 1933, and Part 21E of the Securities Alternate Act of 1934. Ahead-looking statements are topic to important dangers and uncertainties, and precise outcomes might differ materially from these projected. There might be no assurance that Stratasys will have the ability to full the transaction on the anticipated phrases, or in any respect. Vital elements that might trigger precise outcomes and developments to vary materially from these anticipated in these forward-looking statements embody, amongst different issues, dangers and uncertainties associated to market circumstances, satisfaction of customary closing circumstances associated to the transaction and the chance elements and different issues referred to beneath “Threat Components”, and usually in Stratasys’ Annual Report on Kind 20-F for the yr ended December 31, 2023 filed with the U.S. Securities and Alternate Fee, or SEC, on March eleventh, 2024, and in different stories that Stratasys furnishes to or information with the SEC every so often. Readers are urged to rigorously assessment and take into account the assorted disclosures made in Stratasys’ SEC stories, that are designed to advise events of the dangers and different elements which will have an effect on its enterprise, monetary situation, outcomes of operations and prospects. The forward-looking statements on this launch converse solely as of this date, and Stratasys disclaims any intent or obligation to revise or replace publicly any forward-looking assertion besides as required by regulation.
View supply model on businesswire.com: https://www.businesswire.com/information/residence/20240619265067/en/
